In Huntington’s disease (HD), the medium spiny projection neurons of the neostriatum degenerate early in the course of the disease. While genetic mutant models of HD provide an excellent resource for studying the molecular and cellular effects of the inherited polyQ huntingtin mutation, they do not typically present with overt atrophy of the basal ganglia, despite this being a major pathophysiological hallmark of the disease. By contrast, excitotoxic lesion models, which use quinolinic acid to specifically target the striatal projection neurons, are employed to study the functional consequences of striatal atrophy and to investigate potential therapeutic interventions that target the neuronal degeneration. This chapter provides a detailed guide to the generation of excitotoxic lesion models of HD in rats.
CITATION STYLE
Lelos, M. J., & Dunnett, S. B. (2018). Generating excitotoxic lesion models of Huntington’s disease. In Methods in Molecular Biology (Vol. 1780, pp. 209–220). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7825-0_11
Mendeley helps you to discover research relevant for your work.